ARS Pharmaceuticals

SAN DIEGO, June 20, 2023 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and caregivers to better…

<!-- Name:DistributionId Value:8837977 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…

<!-- Name:DistributionId Value:8755578 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False -->…